Pacira Biosciences Inc (PCRX)

May 05, 2026

Pacira BioSciences Mails Letter to Stockholders - The Manila Times

May 05, 2026

May 05, 2026

PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety - ChartMill

May 05, 2026

May 04, 2026

How Pacira’s Q1 2026 Results, EXPAREL Data and Proxy Battle May Impact Pacira BioSciences (PCRX) Investors - Sahm

May 04, 2026

May 03, 2026

Price-Driven Insight from (PCRX) for Rule-Based Strategy - Stock Traders Daily

May 03, 2026

May 03, 2026

Assessing Pacira BioSciences (PCRX) Valuation After Earnings Update And New EXPAREL Real World Data - Yahoo Finance

May 03, 2026

May 02, 2026

Pacira Biosciences Q1 Non-GAAP Earnings Fall, Revenue Rises; 2026 Sales Forecast Maintained - Moomoo

May 02, 2026

May 02, 2026

Universal Beteiligungs und Servicegesellschaft mbH Boosts Stock Position in Pacira BioSciences, Inc. $PCRX - MarketBeat

May 02, 2026

May 02, 2026

Pacira BioSciences (PCRX) Return To Profitability Tests Bullish Growth Narratives - Sahm

May 02, 2026

May 02, 2026

Pacira BioSciences Reports Strong First Quarter Growth for EXPAREL - HarianBasis.co

May 02, 2026

May 01, 2026

MSN Money - MSN

May 01, 2026

May 01, 2026

PCRX Maintained by RBC Capital -- Price Target Raised to $24 - GuruFocus

May 01, 2026

May 01, 2026

PCRX Maintained by Needham -- Price Target Raised to $32 - GuruFocus

May 01, 2026

May 01, 2026

Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y - The Globe and Mail

May 01, 2026

May 01, 2026

Royal Bank Of Canada Issues Positive Forecast for Pacira BioSciences (NASDAQ:PCRX) Stock Price - MarketBeat

May 01, 2026

May 01, 2026

Pacira BioSciences Stock (US6951271005): Analyst Rating Change and Price Move on May 1, 2026 - AD HOC NEWS

May 01, 2026

May 01, 2026

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up Following Analyst Upgrade - MarketBeat

May 01, 2026

May 01, 2026

RBC Raises Price Target on Pacira Biosciences to $24 From $22, Keeps Sector Perform Rating - marketscreener.com

May 01, 2026

May 01, 2026

Vanguard Capital Management (PCRX) reports 2.09M-share stake in Pacira - Stock Titan

May 01, 2026

May 01, 2026

Vanguard Portfolio Management (PCRX) reports 2.59M shares, 6.38% stake - Stock Titan

May 01, 2026

May 01, 2026

Pacira (PCRX) Q1 2026 Earnings Call Transcript - AOL.com

May 01, 2026

May 01, 2026

Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release - Yahoo Finance

May 01, 2026

May 01, 2026

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 01, 2026

May 01, 2026

Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release - The Motley Fool

May 01, 2026

May 01, 2026

Pacira BioSciences Inc (PCRX) Q1 2026 Earnings Call Highlights: Strong Product Growth Amidst Challenges - GuruFocus

May 01, 2026

May 01, 2026

Pacira outlines 2026 revenue guidance of $745M-$770M while advancing PCRX-201 Phase II milestones - MSN

May 01, 2026

Apr 30, 2026

Pacira BioSciences (NASDAQ:PCRX) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences Q1 2026 Earnings Call Transcript - MarketBeat

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences Q1 Earnings Call Highlights - MarketBeat

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PCRX) 2026-04-30 - Seeking Alpha

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences : Corporate Sustainability Report (pacira corporate sustainability report 2024 v1 20260430) - marketscreener.com

Apr 30, 2026

Apr 30, 2026

Is Pacira BioSciences (PCRX) Undervalued After Q1 2026? GAAP EPS - GuruFocus

Apr 30, 2026

Apr 30, 2026

PCRX Sets Ambitious Goals for FY26 with Strong Clinical Focus - GuruFocus

Apr 30, 2026

Apr 30, 2026

Do options traders know something about Pacira BioSciences stock we don't? - MSN

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences (PCRX) Reports Strong Q1 Revenue Growth - GuruFocus

Apr 30, 2026

Apr 30, 2026

Pacira Biosciences (NASDAQ:PCRX) Q1 2026 Results Beat Estimates as Key Pipeline Catalysts Near - ChartMill

Apr 30, 2026

Apr 30, 2026

Q1 2026 Pacira Biosciences Inc Earnings Call Transcript - GuruFocus

Apr 30, 2026

Apr 30, 2026

Earnings Flash (PCRX) Pacira BioSciences, Inc. Posts Q1 Adjusted EPS $0.60 per Share, vs. FactSet Est of $0.55 - marketscreener.com

Apr 30, 2026

Apr 30, 2026

Earnings Flash (PCRX) Pacira BioSciences, Inc. Reports Q1 Revenue $177.4M, vs. FactSet Est of $171.8M - marketscreener.com

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences (NASDAQ: PCRX) Q1 2026 revenue reaches $177M - Stock Titan

Apr 30, 2026

Apr 30, 2026

[8-K] Pacira BioSciences, Inc. Reports Material Event - Stock Titan

Apr 30, 2026

Apr 30, 2026

Pacira BioSciences 1Q EPS 7c >PCRX - Moomoo

Apr 30, 2026

Apr 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 30, 2026

Apr 29, 2026

Pacira BioSciences Inc. (PCRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative

Apr 29, 2026

Apr 28, 2026

Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders - The Manila Times

Apr 28, 2026

Apr 28, 2026

Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025 - 富途牛牛

Apr 28, 2026

Apr 27, 2026

Is It Too Late to Buy Pacira BioSciences Inc (PCRX) After 4.3% R - GuruFocus

Apr 27, 2026